Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Immuron Ltd Regulatory Filings 2017

Sep 29, 2017

35121_ffr_2017-09-29_bcec7d88-131b-49c3-990d-3da3221778dc.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

6-K 1 s107627_6k.htm 6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the Month of September 2017

Commission File Number:

IMMURON LIMITED

(Name of Registrant)

Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia 3053

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐ ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

Field: Page; Sequence: 1; Options: NewSection; Value: 60

Field: /Page

IMMURON LIMITED

EXHIBITS

Exhibit Number Description
99.1 IMC Annual Report 2017
99.2 IMC Appendix 4G
99.3 IMC - Corporate Governance Statement & Skills Matrix

Field: Page; Sequence: 2; Value: 60

Field: /Page

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

IMMURON LIMITED
Date: September 28,
2017 By: /s/
Peter Vaughan
Peter Vaughan
Joint Chief Financial Officer

Field: Page; Sequence: 1; Options: Last

Field: /Page